Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Change in Accured Expenses (2016 - 2026)

Krystal Biotech's Change in Accured Expenses history spans 6 years, with the latest figure at -$6.3 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 270.83% to -$6.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $4.1 million, a 71.25% decrease, with the full-year FY2025 number at $14.1 million, up 161.62% from a year prior.
  • Change in Accured Expenses hit -$6.3 million in Q1 2026 for Krystal Biotech, down from $5.8 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for KRYS hit a ceiling of $7.5 million in Q4 2024 and a floor of -$6.3 million in Q1 2026.
  • Historically, Change in Accured Expenses has averaged $1.3 million across 5 years, with a median of $1.9 million in 2024.
  • Biggest five-year swings in Change in Accured Expenses: surged 629.35% in 2022 and later crashed 272.03% in 2023.
  • Tracing KRYS's Change in Accured Expenses over 5 years: stood at $2.2 million in 2022, then skyrocketed by 70.75% to $3.7 million in 2023, then soared by 103.18% to $7.5 million in 2024, then decreased by 22.68% to $5.8 million in 2025, then tumbled by 209.09% to -$6.3 million in 2026.
  • Business Quant data shows Change in Accured Expenses for KRYS at -$6.3 million in Q1 2026, $5.8 million in Q4 2025, and $5.9 million in Q3 2025.